Improved outcome of elderly patients (≤75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel

Circulation

Volumn 95, Issue 2, 1997, Pages 342-350

  Gottlieb, Shmuel ^b   Goldbourt, Uri ^a   Boyko, Valentina ^a   Barbash, Gabriel ^a   Mandelzweig, Lori ^a   Reicher Reiss, Henrietta ^a   Stern, Shlomo ^b   Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BIKUR CHOLIM HOSPITAL   (Israel)

Author keywords

aging; myocardial infarction; reperfusion; survival; thrombolysis

Indexed keywords

ACUTE HEART INFARCTION; AGING; ARTICLE; BLOOD CLOT LYSIS; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

EID: 0031037120     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.2.342     Document Type: Article

References (10)

1. GISSI Study Group. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction: Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1986; 1:397-402.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187.cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
3. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation. 1990;82(suppl II):II-117-II-134.
4. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994; 343:311-322.
5. Schlant RC, O'Rourke RA, Collen D, Kennedy JW, Kuschnir E, Meyer J, Paoletti R, Pitt B, Rapaport E, Sekiguchi M, Simoons ML, Sleight P. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion: reperfusion in acute myocardial infarction. Circulation. 1994;90: 2091-2102.
6. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore J, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD, for the Participants in the National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States (1990 to 1993): observations from national registry of myocardial infarction. Circulation. 1994; 90:2103-2114.
7. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Mean J. 1988;115:761-767.
8. de Vreede JJM, Gorgels APM, Verstraaten GMP, Vermeer F, Dassen VRM, Wellens HJJ. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol. 1991:18:698-706.
9. Dellborg M, Eriksson P, Riha M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J. 1994;15:5-9.
10. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol. 1994;24:1431-1438.